Ledger.Open graph →

SEC Form D · filed June 13, 2018

Avant Diagnostics, Inc

Offering

$2.0M

Sold

$1.2M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WASHINGTON, Washington, D.C.

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Scott Vandermeer · Washington, Washington, D.C.Exec Jeff Stephens · San Francisco, CADirector Michael Ruxin, M.D · Washington, Washington, D.C.Exec Jeff Busch · Washington, Washington, D.C.Director Robert Trapp · Washington, Washington, D.C.Director John Brugmann · Washington, Washington, D.C.Director Michael Ruxin, M.D · Washington, Washington, D.C.Exec Scott Vandermeer · Washington, Washington, D.C.Exec Jeff Busch · Washington, Washington, D.C.Director Robert Trapp · Washington, Washington, D.C.Director John Brugmann · Washington, Washington, D.C.Director Jeff Stephens · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗